SE7905830L - Forfarande for framstellning av en steril, injicerbar fysiologiskt acceptabel losning av ett rontgenkontrastmedel och losningar av rontgenkontrastmedlet och en buffert - Google Patents

Forfarande for framstellning av en steril, injicerbar fysiologiskt acceptabel losning av ett rontgenkontrastmedel och losningar av rontgenkontrastmedlet och en buffert

Info

Publication number
SE7905830L
SE7905830L SE7905830A SE7905830A SE7905830L SE 7905830 L SE7905830 L SE 7905830L SE 7905830 A SE7905830 A SE 7905830A SE 7905830 A SE7905830 A SE 7905830A SE 7905830 L SE7905830 L SE 7905830L
Authority
SE
Sweden
Prior art keywords
rontgen
contractor
physiologically acceptable
solutions
sterile
Prior art date
Application number
SE7905830A
Other languages
English (en)
Other versions
SE445971B (sv
Inventor
F B Rakli
M J Kelly
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of SE7905830L publication Critical patent/SE7905830L/sv
Publication of SE445971B publication Critical patent/SE445971B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SE7905830A 1978-07-04 1979-07-03 Forfarande for framstellning av injicerbart rontgenkontrastmedel samt en losning av nemnda medel SE445971B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7828764 1978-07-04
KR1019790002214A KR830001643B1 (ko) 1978-07-04 1979-07-03 X-선 조영제의 생리적으로 허용되는 멸균 주사용 용액을 제조하는 방법

Publications (2)

Publication Number Publication Date
SE7905830L true SE7905830L (sv) 1980-01-05
SE445971B SE445971B (sv) 1986-08-04

Family

ID=26268114

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7905830A SE445971B (sv) 1978-07-04 1979-07-03 Forfarande for framstellning av injicerbart rontgenkontrastmedel samt en losning av nemnda medel

Country Status (22)

Country Link
US (2) US4278654A (sv)
JP (1) JPS5531068A (sv)
KR (1) KR830001643B1 (sv)
AR (1) AR222337A1 (sv)
AT (1) AT371998B (sv)
AU (1) AU523295B2 (sv)
BE (1) BE877443A (sv)
CA (1) CA1132901A (sv)
CH (1) CH649469A5 (sv)
DE (1) DE2926850C2 (sv)
DK (1) DK155714C (sv)
ES (1) ES482131A0 (sv)
FI (1) FI75492C (sv)
FR (1) FR2435253A1 (sv)
HK (1) HK59984A (sv)
IT (1) IT1193761B (sv)
NL (1) NL183121C (sv)
NZ (1) NZ190907A (sv)
PT (1) PT69869A (sv)
SE (1) SE445971B (sv)
SG (1) SG5784G (sv)
ZA (1) ZA793313B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150916A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US4396598A (en) * 1982-01-11 1983-08-02 Mallinckrodt, Inc. Triiodoisophthalamide X-ray contrast agent
US5035877A (en) * 1985-08-09 1991-07-30 Cook Imaging Corporation Non-ionic contrast media from ionic contrast media
DE3689330T2 (de) * 1985-08-09 1994-05-19 Cook Imaging Corp Nichtionische polyolkontrastmittel aus ionischen kontrastmitteln.
US4718463A (en) * 1985-12-20 1988-01-12 Mallinckrodt, Inc. Method of producing prefilled sterile plastic syringes
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
IL94718A (en) * 1989-07-05 1994-10-21 Schering Ag Non-ionic carboxamide contrast agent and method of preparation
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
US5075502A (en) * 1989-12-13 1991-12-24 Mallinckrodt, Inc. Nonionic x-ray contrast agents, compositions and methods
US5191120A (en) * 1989-12-13 1993-03-02 Mallinckrodt Medical, Inc. Process for preparing nonionic X-ray contrast agents
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
DE4316722A1 (de) * 1993-05-19 1994-11-24 Fresenius Ag Parenteral verabreichbare, unter Hitzesterilisationsbedingungen stabile O/W-Emulsion eines Röntgenkontrastmittels
ES2208884T3 (es) * 1996-01-25 2004-06-16 Schering Aktiengesellschaft Soluciones mejoradas de agentes de contraste para la administracion intravasal.
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
US6072069A (en) * 1998-11-04 2000-06-06 Biophysica, Inc. Biodegradable nonionic contrast media
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance
MX2012010959A (es) * 2010-03-23 2012-11-23 Ge Healthcare As Preparacion de composicion diagnostica de rayos x estabilizada.
US20140377185A9 (en) * 2012-05-30 2014-12-25 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3190E (fr) * 1904-09-30 Jules Cesar Napoleon Fouilloy Collier d'attache pour protecteur antidérapant de pneumatiques
NL127881C (sv) * 1963-03-25
GB1069437A (en) * 1963-10-23 1967-05-17 Nyegaard & Co As Injectable x-ray contrast media
US3733397A (en) * 1966-12-02 1973-05-15 Pharmacia Ab Method for the x-ray visualization of body cavities and a preparation for carrying out the method
SE315975B (sv) * 1967-12-28 1969-10-13 Pharmacia Ab
US4021481A (en) * 1969-06-27 1977-05-03 Nyegaard & Co. A/S Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
GB1321591A (en) * 1969-06-27 1973-06-27 Nyegaard & Co As Non-ionic iodinated x-ray contrast agents
CH583562A5 (sv) * 1973-07-17 1977-01-14 Bracco Ind Chimica Spa
GB1495679A (en) * 1974-06-17 1977-12-21 Mallinckrodt Inc Substituted isophthalamic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof
GB1514920A (en) * 1974-10-09 1978-06-21 Reckitt & Colmann Prod Ltd Dispensing container for medicinal foams
FI760068A7 (sv) * 1975-02-03 1976-08-04 Schering Ag
DE2505218A1 (de) * 1975-02-05 1976-08-19 Schering Ag Neue orale roentgenkontrastmittel und verfahren zu ihrer herstellung
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same

Also Published As

Publication number Publication date
DE2926850C2 (de) 1985-01-24
US4396597A (en) 1983-08-02
DE2926850A1 (de) 1980-03-06
ATA464479A (de) 1983-01-15
PT69869A (en) 1979-08-01
AU523295B2 (en) 1982-07-22
JPS5531068A (en) 1980-03-05
ZA793313B (en) 1980-08-27
FR2435253A1 (fr) 1980-04-04
CH649469A5 (de) 1985-05-31
NL183121C (nl) 1988-08-01
AT371998B (de) 1983-08-25
AU4861579A (en) 1980-02-07
BE877443A (fr) 1980-01-03
DK155714C (da) 1989-10-30
ES8200082A1 (es) 1980-12-16
AR222337A1 (es) 1981-05-15
JPS6210209B2 (sv) 1987-03-05
FI75492B (fi) 1988-03-31
NL7905166A (nl) 1980-01-08
SG5784G (en) 1985-02-01
FR2435253B1 (sv) 1984-03-16
DK280979A (da) 1980-01-05
CA1132901A (en) 1982-10-05
NL183121B (nl) 1988-03-01
ES482131A0 (es) 1980-12-16
KR830001643B1 (ko) 1983-08-22
KR830000911A (ko) 1983-04-28
HK59984A (en) 1984-08-10
FI792101A7 (fi) 1980-01-05
US4278654A (en) 1981-07-14
FI75492C (sv) 1988-07-11
SE445971B (sv) 1986-08-04
DK155714B (da) 1989-05-08
IT1193761B (it) 1988-08-24
NZ190907A (en) 1981-10-19
IT7949618A0 (it) 1979-07-03

Similar Documents

Publication Publication Date Title
SE7905830L (sv) Forfarande for framstellning av en steril, injicerbar fysiologiskt acceptabel losning av ett rontgenkontrastmedel och losningar av rontgenkontrastmedlet och en buffert
ES475854A1 (es) Un procedimiento para preparar derivados de glicosido de pleuromutilina
UA29483C2 (uk) Спосіб і пристрій для термостерилізації або дезинфекції відходів
FI834277A0 (fi) Steriliseringsbehandling med vaetesuperoxid och neutralisering av dennas restmaengder
ES2037752T3 (es) Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion.
SE8306994D0 (sv) Cefemderivat och forfarande for deras framstellning
DK130883D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
ES8403722A1 (es) Procedimiento para inactivar el virus de la hepatitis b.
DE3855220D1 (de) Methode zur beseitigung von infektionserregern in geweben
SE8305878L (sv) Nya azolforeningar
EP0124596A4 (en) Chemical sterilization of implantable biological tissue.
TR200000865T2 (tr) Steril örtü
ATE63670T1 (de) Auf alkohol basierende antimikrobische zusammensetzungen und verfahren zur erhoehung deren wirksamkeit.
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
SE7512828L (sv) Calicivirusvaccin
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
ATE67507T1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE7902866L (sv) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
Trexler Germ-free isolators
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
ES2056947T3 (es) Productos opticamente activos de derivados de 20,21-dinoreburnamenina, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
PT85100A (pt) Processo para a preparacao de novos tetra-hidro-benzotiazois e de composicoes farmaceuticas que os contem
ES2151572T3 (es) Benzoilguanidinas sustituidas con trifluoropropilo y su empleo como medicamento o agente de diagnostico.
ES2064948T3 (es) Polimetilen-iminas disustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7905830-1

Format of ref document f/p: F